The DOI matches its Crossref record; 269 of the 275 references it cites were found in a registry or an index.
The evolution of commercial drug delivery technologies
Abstract
Drug delivery technologies have enabled the development of many pharmaceutical products that improve patient health by enhancing the delivery of a therapeutic to its target site, minimizing off-target accumulation and facilitating patient compliance. As therapeutic modalities expanded beyond small molecules to include nucleic acids, peptides, proteins and antibodies, drug delivery technologies were adapted to address the challenges that emerged. In this Review Article, we discuss seminal approaches that led to the development of successful therapeutic products involving small molecules and macromolecules, identify three drug delivery paradigms that form the basis of contemporary drug delivery and discuss how they have aided the initial clinical successes of each class of therapeutic. We also outline how the paradigms will contribute to the delivery of live-cell therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The ultimate goal of the development of smart nanoparticles is that the payloads can better serve patients: enhance curative effect, reduce toxicity and prolong survival.276”
From Smart nanoparticles for cancer therapy (2023) · cites this paper as [276]
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,484
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Baden, L. R., El Sahly, H. M., Essink, B., Kotloff, K., Frey, S., Novak, R., Diemert, D., Spector, S. A., Rouphael, N., Creech, C. B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035389 · Cited by 10,119
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia
Maude, S. L., Laetsch, T. W., Buechner, J., Rives, S., Boyer, M., Bittencourt, H., Bader, P., Verneris, M. R., Stefanski, H. E., Myers, G. D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1709866 · Cited by 5,735
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552
Research works printed but not linked: 2
- Dost, F. H. Der Blutspiegel: Kinetik der Konzentrationsabläufe in der Kreislaufflüssigkeit (Georg Thieme, 1953).
- DeLoach, J. R. & Sprandel, U. (eds) in Bibliotheca Haematologica Vol. 51 (Karger, 1985).
Cited by
Sorted by citations
Items 201–300 of 1,000
Recent Advances of Tumor Therapy Based on the CD47-SIRPα Axis
Wang, Y., Zhao, C., Liu, Y., Wang, C., Jiang, H., Hu, Y., & Wu, J. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00073 · Cited by 43
Bottom-up design of hydrogels for programmable drug release
Owh, C., Ow, V., Lin, Q., Wong, J. H. M., Ho, D., Loh, X. J., & Xue, K. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.213100 · Cited by 42
Electrochemical Single‐Cell Protein Therapeutics Using a Double‐Barrel Nanopipette
Shi, X., Xu, Y., Zhou, B., Wang, B., Yu, S., Zhao, W., Jiang, D., Chen, H., & Xu, J. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202215801 · Cited by 42
Peptide-nanoparticle conjugates as a theranostic platform
Kim, S., No, Y. H., Sluyter, R., Konstantinov, K., Kim, J. H., & Kim, J. H. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215530 · Cited by 46
Huang, S., Zhu, W., Zhang, F., Chen, G., Kou, X., Yang, X., Ouyang, G., & Shen, J. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c18053 · Cited by 42
The past, present, and future of chemotherapy with a focus on individualization of drug dosing
DeRidder, L. B., Rubinson, D. A., Langer, R., & Traverso, G. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.10.043 · Cited by 42
Esfahani, S., Akbari, J., Soleimani‐Amiri, S., Mirzaei, M., & Gol, A. G. (2023) · Diamond and Related Materials · doi:10.1016/j.diamond.2023.109893 · Cited by 41
Zhu, K., Xu, Y., Zhong, R., Li, W., Wang, H., Wong, Y. S., Venkatraman, S., Liu, J., & Cao, Y. (2023) · Regenerative Biomaterials · doi:10.1093/rb/rbad045 · Cited by 41
“Despite apparent advantages, the clinical utilization of the liposomes is hindered due to some limitations [2].”
BackgroundA novel antimicrobial strategy for bacterial infections: Gallium-based materials
Shi, F., Ma, S., Liu, S., Xin, R., Chen, B., Ye, W., & Sun, J. (2023) · Colloids and Interface Science Communications · doi:10.1016/j.colcom.2023.100735 · Cited by 43
Grundler, J., Shin, K., Suh, H., Whang, C., Fulgoni, G., Pierce, R. W., & Saltzman, W. M. (2024) · ACS Nano · doi:10.1021/acsnano.3c05921 · Cited by 45
Neves, B. D., Gonçalves, R. C., Mano, J. F., & Oliveira, M. B. (2024) · Green Chemistry · doi:10.1039/d3gc04183b · Cited by 42
Lin, H., Yang, Y., Wang, X., Chung, M., Zhang, L., Cai, S., Pan, X., & Pan, Y. C. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1667620 · Cited by 49
“Localized delivery and transient inhibition may contribute to mitigating such risks (137).”
Tomeh, M. A., Mansor, M. H., Hadianamrei, R., Sun, W., & Zhao, X. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121762 · Cited by 41
Recent Advances in Drug Delivery System Fabricated by Microfluidics for Disease Therapy
Jia, F., Gao, Y., & Wang, H. (2022) · Bioengineering · doi:10.3390/bioengineering9110625 · Cited by 40
“Macroscopic delivery systems such as drug-eluting stents require surgical implantation and may induce fibrocystic reaction [9].”
BackgroundMilk Exosomes Facilitate Oral Delivery of Drugs against Intestinal Bacterial Infections
Qu, S., Han, Y., Liu, Y., Zhu, J., Acaröz, U., Shen, J., & Zhu, K. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c04971 · Cited by 42
Structure–Activity Relationship of pH-Sensitive Doxorubicin-Fatty Acid Prodrug Albumin Nanoparticles
Yang, Y., Li, X., Song, J., Li, L., Ye, Q., Zuo, S., Liu, T., Dong, F., Liu, X., He, Z., et al. (2023) · Nano Letters · doi:10.1021/acs.nanolett.2c04976 · Cited by 40
Ocular Delivery of Therapeutic Agents by Cell-Penetrating Peptides
Nhàn, N. T. T., Maidana, D. E., & Yamada, K. H. (2023) · Cells · doi:10.3390/cells12071071 · Cited by 40
“In addition, they limit the application of less soluble molecules [95].”
BackgroundScalable production of microscopic particles for biological delivery
Lin, H., Leng, J., Fan, P., Xu, Z., & Ruan, G. (2023) · Materials Advances · doi:10.1039/d3ma00021d · Cited by 40
Cheng, G., Wang, Q., Ding, Y., Kwong, C. H. T., Liu, J., Xie, B., Wei, J., Lee, S. M., Mok, G. S. P., & Wang, R. (2024) · Nature Communications · doi:10.1038/s41467-023-44662-5 · Cited by 41
“Thus, immune cells have recently been investigated as the next generation drug carriers 17,18 .”
Advances in acid-degradable and enzyme-cleavable linkers for drug delivery
Zhao, S., Yu, N., Han, H., Guo, S., & Murthy, N. (2024) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2024.102552 · Cited by 42
Recent advances in functional lipid-based nanomedicines as drug carriers for organ-specific delivery
Yun, Y., An, J., Kim, H. J., Choi, H. K., & Cho, H. (2025) · Nanoscale · doi:10.1039/d4nr04778h · Cited by 45
Synthetic and Biogenic Materials for Oral Delivery of Biologics: From Bench to Bedside
Ding, S., Alexander, E., Liang, H., Kulchar, R. J., SINGH, R. K., Herzog, R. W., Daniell, H., & Leong, K. W. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00482 · Cited by 43
Bayan, M. A. H., Dias, Y. J., Rinoldi, C., Nakielski, P., Rybak, D., Truong, Y. B., Yarin, A. L., & Pierini, F. (2023) · Journal of Polymer Science · doi:10.1002/pol.20220747 · Cited by 39
Yao, M., Yan, Z., Sun, X., Guo, B., Yu, C., Zhao, Z., Li, X., Tan, Z., Zhang, H., Yao, F., et al. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.05.003 · Cited by 39
Das, T., & Sultana, S. (2024) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-023-00577-y · Cited by 39
Gorantla, S., Batra, U., Samshritha, R. N., Puppala, E. R., Waghule, T., Naidu, V. G. M., & Singhvi, G. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2053674 · Cited by 39
Anticancer Applications of Essential Oils Formulated into Lipid-Based Delivery Nanosystems
Jampílek, J., & Kráľová, K. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122681 · Cited by 45
Unleashing cell-penetrating peptide applications for immunotherapy
Koo, J., Kim, G., Nam, K.-H., & Choi, J. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.03.010 · Cited by 41
Oral delivery of nucleic acid therapeutics: Challenges, strategies, and opportunities
Jiang, X., Wang, N., Liu, C., Zhuo, Y., Li, L., Gan, Y., & Yu, M. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103507 · Cited by 38
Trends in smart drug delivery systems for targeting cancer cells
Kandula, S., Singh, P. K., Kaur, G. A., & Tiwari, A. (2023) · Materials Science and Engineering B · doi:10.1016/j.mseb.2023.116816 · Cited by 38
Antigen/adjuvant‐free liposome induces adjuvant effects for enhancing cancer immunotherapy
Guo, Q., Xu, X., Lai, X., Duan, J., Yan, D., & Wang, D. (2024) · Exploration · doi:10.1002/exp.20230115 · Cited by 38
Judy, E., Lopus, M., & Kishore, N. (2021) · RSC Advances · doi:10.1039/d1ra06057k · Cited by 40
Wang, Q., Wang, C., Li, S., Xiong, Y., Wang, H., Li, Z., Wan, J., Yang, X., & Li, Z. (2022) · Chemistry of Materials · doi:10.1021/acs.chemmater.1c03346 · Cited by 38
Microfluidic approaches for producing lipid-based nanoparticles for drug delivery applications
Piunti, C., & Cimetta, E. (2023) · Biophysics Reviews · doi:10.1063/5.0150345 · Cited by 37
Halder, S., Das, T., Kushwaha, R., Misra, A. K., Jana, K., & Das, D. (2024) · Materials Horizons · doi:10.1039/d4mh00981a · Cited by 37
Macrophage hitchhiking nanomedicine for enhanced β-elemene delivery and tumor therapy
Chen, S., Li, Y., Zhou, Z., Saiding, Q., Zhang, Y., An, S., Khan, M. M., Ji, X., Qiao, R., Tao, W., et al. (2025) · Science Advances · doi:10.1126/sciadv.adw7191 · Cited by 37
“Unlike conventional drug delivery systems, living cells exhibit the inherent capability to transverse through the animal body ( 8 , 9 ), potentially serving as hitchhiking delivery systems by rerouting the nanoparticle-based drug delivery system.”
Programmable manipulation of oligonucleotide–albumin interaction for elongated circulation time
Cai, Y., Zhao, H., Sun, Y., Wang, C., Geng, X., Wang, R., Tang, L., Han, D., Liu, J., & Tan, W. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac156 · Cited by 37
Antibiotic-loaded lipid-based nanocarrier: A promising strategy to overcome bacterial infection
Henostroza, M. A. B., Tavares, G. D., Yukuyama, M. N., de Souza, A., Barbosa, E. J., Avino, V. C., Neto, E. D. S., Lourenço, F. R., Löbenberg, R., & Bou‐Chacra, N. A. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121782 · Cited by 38
Tomeh, M. A., Hadianamrei, R., Xu, D., Brown, S., & Zhao, X. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.112549 · Cited by 38
Micro and nanotechnologies: The little formulations that could
Stiepel, R. T., Duggan, E., Batty, C. J., & Ainslie, K. M. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10421 · Cited by 38
“it to clinical trials and has received FDA approval (Table 1).(32,199)”
Drug delivery systems for colorectal cancer chemotherapy
Chen, W., Shi, K. Y., Yu, Y., Yang, P., Bei, Z., Mo, D., Yuan, L., Pan, M., Chen, Y., & Qian, Z. (2023) · Chinese Chemical Letters · doi:10.1016/j.cclet.2023.109159 · Cited by 36
Exogeneous metal ions as therapeutic agents in cardiovascular disease and their delivery strategies
Hong, X., Tian, G., Zhu, Y., & Ren, T. (2023) · Regenerative Biomaterials · doi:10.1093/rb/rbad103 · Cited by 39
“In addition, the targeted organ delivery ability of nanoparticles can minimize the side effects and toxicity to other organs [125, 126].”
BackgroundExtracellular vesicles in degenerative retinal diseases: A new therapeutic paradigm
Manai, F., Smędowski, A., Kaarniranta, K., Comincini, S., & Amadio, M. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.11.035 · Cited by 37
Pharmaceutical Applications of Biomass Polymers: Review of Current Research and Perspectives
Bejenaru, C., Radu, A., Segneanu, A., Biţă, A., Ciocîlteu, M. V., Mogoşanu, G. D., Bradu, I.-A., Vlase, T., Vlase, G., & Bejenaru, L. E. (2024) · Polymers · doi:10.3390/polym16091182 · Cited by 37
Polyimide as a biomedical material: advantages and applications
Shu, J., Zhou, Z., Liang, H., & Yang, X. (2024) · Nanoscale Advances · doi:10.1039/d4na00292j · Cited by 36
Lin, C. X., Yang, K., Li, P. C., Gao, L. T., Aziz, Y., Li, J. H., Miyatake, H., Ito, Y., & Chen, Y. M. (2024) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2024.114089 · Cited by 36
AL-Rajabi, M. M., Alzyod, S., Patel, A., & Teow, Y. H. (2025) · Polymer Bulletin · doi:10.1007/s00289-025-05645-2 · Cited by 36
“Of these, hydrogels stand out as a particularly innovative DDS, enhancing drug t 50% and enabling targeted delivery to specific tissues through tailored interactions with the environment [3].”
InfluentialAntiviral drug discovery and development: challenges and future directions
Du, S., Hu, X., Li, P., Xu, S., Kim, M., Liu, X., & Zhan, P. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02539-7 · Cited by 41
“299 300 – 302 Owing to the remarkable ef fi cacy demonstrated by CAR-T-cell therapy in numerous clinical trials involving hematologic malignancies, its safety, feasibility, effectiveness, and durability have been con fi rmed.”
Liu, J., Sheng, J., Shao, L., Zheng, Q., Li, W., Chen, X., Mao, L., & Wang, M. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202111213 · Cited by 36
Efficient Antibacterial Agent Delivery by Mesoporous Silica Aerogel
Xie, H., He, Z., Liu, Y., Zhao, C., Guo, B., Zhu, C., & Xu, J. Z. (2022) · ACS Omega · doi:10.1021/acsomega.1c06198 · Cited by 36
Chen, Y., Wu, T., Xie, S., Bai, Y., & Xing, H. (2023) · Science Advances · doi:10.1126/sciadv.adg2583 · Cited by 35
Tian, L., Han, S., Wu, W. D., Li, Z., He, Z., Liu, C., Xue, H., Zhou, F., Liu, J., & Liu, J. (2024) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2024.10.162 · Cited by 35
New opportunities of stimulus-responsive smart nanocarriers in cancer therapy
Liu, X., He, F., & Liu, M. (2024) · Nano Materials Science · doi:10.1016/j.nanoms.2024.10.013 · Cited by 35
Liu, R., Wu, Q., Huang, X., Zhao, X., Chen, X., Chen, Y., Weitz, D. A., & Song, Y. (2021) · RSC Advances · doi:10.1039/d1ra05207a · Cited by 35
Das, D., Roy, A., & Pal, S. (2023) · ACS Applied Polymer Materials · doi:10.1021/acsapm.2c02256 · Cited by 35
Structural determinants of stimuli-responsiveness in amphiphilic macromolecular nano-assemblies
Liu, H., Lu, H., Alp, Y., Wu, R., & Thayumanavan, S. (2023) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2023.101765 · Cited by 35
Bocci, M., Zana, A., Principi, L., Lucaroni, L., Prati, L., Gilardoni, E., Neri, D., Cazzamalli, S., & Galbiati, A. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.02.014 · Cited by 34
Ma, D., Xie, A., Lv, J., Min, X., Zhang, X., Zhou, Q., Gao, D., Wang, E., Gao, L., Cheng, L., et al. (2024) · Protein & Cell · doi:10.1093/procel/pwae015 · Cited by 36
“2018; Lokugamage et al., 2021; Machtakova et al., 2022; Paunovska et al., 2022; Vargason et al., 2021; Yang et al., 2023; Zong et al., 2023).”
Mucus-Penetrable Biomimetic Nanoantibiotics for Pathogen-Induced Pneumonia Treatment
Wang, Y., Ding, Q., Ma, G., Zhang, Z., Wang, J., Lu, C., Xiang, C., Qian, K., Zheng, J., Shan, Y., et al. (2024) · ACS Nano · doi:10.1021/acsnano.4c10837 · Cited by 34
Focus on therapeutic peptides and their delivery
Rosson, E., Lux, F., David, L., Godfrin, Y., Tillement, O., & Thomas, E. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125555 · Cited by 36
Engineering (Bio)Materials through Shrinkage and Expansion
Wang, M., Li, W., Tang, G., Garciamendez‐Mijares, C. E., & Zhang, Y. S. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202100380 · Cited by 36
Bacterial exopolysaccharides in drug delivery applications
Saha, I., & Datta, S. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103557 · Cited by 35
Magnetic nanomaterials as drug delivery vehicles and therapeutic constructs to treat cancer
Anjum, T., Hussain, N., Hafsa, H., Iqbal, H. M. N., Jędrzak, A., Jesionowski, T., & Bilal, M. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.104103 · Cited by 36
Transport by circulating myeloid cells drives liposomal accumulation in inflamed synovium
Deprez, J., Verbeke, R., Meulewaeter, S., Aernout, I., Dewitte, H., Decruy, T., Coudenys, J., Duyse, J. V., Isterdael, G. V., Peer, D., et al. (2023) · Nature Nanotechnology · doi:10.1038/s41565-023-01444-w · Cited by 34
“However, in-depth studies that clarify to what extent the myeloid cell transport of non-targeted liposomes contributes to their accumulation into inflamed tissues are currently lacking 20 .”
BackgroundQuazi, M. Z., & Park, N. (2023) · Biomacromolecules · doi:10.1021/acs.biomac.3c00021 · Cited by 33
Greco, A., Gabold, B., Chen, S., Wang, X., Xu, Z., Hartschuh, A., Chiesa, E., Genta, I., Ried, C. L., Merdan, T., et al. (2023) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2023.05.010 · Cited by 37
Rathna, R. P., & Kulandhaivel, M. (2024) · Archives of Microbiology · doi:10.1007/s00203-024-03910-y · Cited by 35
“…to facilitate the administration of a therapeutic drug into the host, thereby enhancing its efficiency, compatibility, target and deliver drugs effectively to the affected tissues that is achieved by regulating the pace, timing, and site of drug release within the body (Vargason et al. 2021).”
Nanomaterials: leading immunogenic cell death-based cancer therapies
Ma, C., Cheng, Z., Tan, H., Wang, Y., Sun, S., Zhang, M., & Wang, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1447817 · Cited by 38
Edible Ultralong Organic Phosphorescent Excipient for Afterglow Visualizing the Quality of Tablets
Peng, Y., Yao, X., Hu, X., Wu, B., Pei, X., Yang, Y., Dong, Z., An, Z., Huang, W., & Cai, T. (2024) · Advanced Materials · doi:10.1002/adma.202406618 · Cited by 33
Computational Methods for Modeling Lipid-Mediated Active Pharmaceutical Ingredient Delivery
Paloncýová, M., Valério, M., dos Santos, R. N., Kührová, P., Šrejber, M., Čechová, P., Dobchev, D. A., Balsubramani, A., Banáš, P., Agarwal, V., et al. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00744 · Cited by 35
Potential of Microneedle Systems for COVID-19 Vaccination: Current Trends and Challenges
Hassan, J., Haigh, C., Ahmed, T., Uddin, M. J., & Das, D. B. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14051066 · Cited by 36
Biodegradable Microrobots for DNA Vaccine Delivery
Chen, S., Tan, Z., Liao, P., Li, Y., Qu, Y., Zhang, Q., Yang, M., Chan, K. W. Y., Zhang, L., Man, K., et al. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202202921 · Cited by 37
Present and Future of ZrO2 Nanostructure as Reservoir for Drug Loading and Release
Radu, R.-D., & Drăgănescu, D. (2023) · Coatings · doi:10.3390/coatings13071273 · Cited by 32
Yuan, S., Ma, T., Zhang, Y., Wang, N., Baloch, Z., & Ma, K. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02159-9 · Cited by 34
“We have moved from viewing TCM as a monomeric entity to recognizing the active protein components of TCMs and from considering only the symptoms that drugs address to the specific targets that drugs regulate [33].”
BackgroundUse of encapsulating polymers of active compounds in the pharmaceutical and food industry
Rojas, K., Verdugo-Molinares, M. G., & Vallejo‐Cardona, A. A. (2024) · Food Chemistry Advances · doi:10.1016/j.focha.2024.100619 · Cited by 34
Han, L., Yuan, Z., Ren, H., Song, W., Wu, R., Li, J., Guo, Z., Yu, B., Duan, S., & Xu, F. (2024) · BMEMat · doi:10.1002/bmm2.12082 · Cited by 32
Form Equals Function: Influence of Coacervate Architecture on Drug Delivery Applications
Lim, C., & McTigue, W. C. B. (2024) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.4c01105 · Cited by 35
Bioinspired approaches to encapsulate and deliver bacterial live biotherapeutic products
Brittain, N. Y., & Finbloom, J. A. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115663 · Cited by 34
Precision Nanomedicine for Cancer: Innovations, Strategies, and Translational Challenges
Wen, F., Wang, L., Li, X., Zhao, J., Xu, T., Zhu, J., Ma, L., & Wang, X. (2025) · OncoTargets and Therapy · doi:10.2147/ott.s550104 · Cited by 36
Man, N. T. H., Biriukov, D., Tempra, C., Baxová, K. L., Martinez‐Seara, H., Evci, H., Singh, V., Šachl, R., Hof, M., Jungwirth, P., et al. (2022) · Langmuir · doi:10.1021/acs.langmuir.2c01435 · Cited by 32
Endorsement of TNBC Biomarkers in Precision Therapy by Nanotechnology
Chaudhuri, A., Kumar, D. N., Dehari, D., Patil, R., Singh, S. K., Kumar, D. K., & Agrawal, A. K. (2023) · Cancers · doi:10.3390/cancers15092661 · Cited by 32
“Such microenvironment modifications aid in navigating biological barriers [157].”
BackgroundAdvancing bioinformatics with language models: components, applications, and perspectives
Liu, J., Yang, M., Yu, Y., Xu, H., Wang, T., Li, K., & Zhou, X. (2026) · Briefings in Bioinformatics · doi:10.1093/bib/bbag367 · Cited by 66
Recent Progress and Challenges Regarding Magnetite-Based Nanoparticles for Targeted Drug Delivery
Kurczewska, J., & Dobosz, B. (2024) · Applied Sciences · doi:10.3390/app14031132 · Cited by 31
Chagas, P. A. M., Guerra, N. B., dos Santos, L. S., Mussagy, C. U., Brasil, G. S. P., Burd, B. S., Su, Y., Sasaki, J. C. D. S., Scontri, M., Filho, P. E. D. L. L., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.131666 · Cited by 31
Acoustothermal transfection for cell therapy
Liu, X., Rong, N., Tian, Z., Rich, J. T., Niu, L., Li, P.-Q., Huang, L., Dong, Y., Zhou, W., Zhang, P., et al. (2024) · Science Advances · doi:10.1126/sciadv.adk1855 · Cited by 31
“…cells such as primary T cells and primary stem cells, the conventional techniques based on viral vectors ( 16 , 17 ), cationic lipids ( 16 – 18 ), or electroporation ( 17 , 19 ) suffer from low delivery efficiencies ( 20 , 21 ), and it is difficult to deliver large nucleic acid to these…”
BackgroundMicelle-Containing Hydrogels and Their Applications in Biomedical Research
Wu, J., Li, H., Zhang, N., & Zheng, Q. (2024) · Gels · doi:10.3390/gels10070471 · Cited by 31
“…could effectively control the drug release in a sustained manner and enhance the Controlled release technologies are essential for tissue and immuno-engineering but often rely on passive diffusion, which largely limits the drug size and hampers the coordination of multiple drug releases [73].”
BackgroundStem Cell Mimicking Nanoencapsulation for Targeting Arthritis
Shin, M. J., Park, J. Y., Lee, D. H., & Khang, D. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s334298 · Cited by 32
Carucci, C., Sechi, G., Piludu, M., Monduzzi, M., & Salis, A. (2022) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2022.129343 · Cited by 31
Coulter, S. M., Pentlavalli, S., Vora, L. K., An, Y., Cross, E. R., Peng, K., McAulay, K., Schweins, R., Donnelly, R. F., McCarthy, H. O., et al. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202203198 · Cited by 31
Self‐Powered Electrically Controlled Drug Release Systems Based on Nanogenerator
Luo, W., Luo, R., Liu, J., Li, Z., & Wang, Y. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202311938 · Cited by 29
Yan, K., Guo, Y., & Liu, B. (2023) · Bioinformatics · doi:10.1093/bioinformatics/btad125 · Cited by 30
“Drug delivery vehicle (DDV) can be utilized to enhance the delivery of drug molecules (Hasan et al., 2021; Vargason et al., 2021).”
BackgroundDesign of double functionalized carbon nanotube for amphotericin B and genetic material delivery
Yazdani, S., Mozaffarian, M., Pazuki, G., Hadidi, N., Gallego, I., Puras, G., & Pedraz, J. L. (2022) · Scientific Reports · doi:10.1038/s41598-022-25222-1 · Cited by 29
Localized Therapeutic Approaches Based on Micro/Nanofibers for Cancer Treatment
Alves, D. I., Araújo, J. C., Fangueiro, R. M. E. S., & Ferreira, D. P. (2023) · Molecules · doi:10.3390/molecules28073053 · Cited by 29
“Considering the high costs, high risk, and the long time associated with the development and research of novel medication, a significant effort is being put into changing its effect [41].”
BackgroundPeng, Z., Ding, Y., Yang, Z.-M., Li, X., Zhuang, Z., Lu, Y., Hang, C., Hang, C.-H., & Li, W. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.03.023 · Cited by 29
Smart Bioorthogonal Nanozymes: From Rational Design to Appropriate Bioapplications
Zhang, B., Zhu, J., Ren, J., & Qu, X. (2024) · Advanced Materials · doi:10.1002/adma.202405318 · Cited by 29
Kim, J., Yoon, H., Viswanath, S., & Dağdeviren, C. (2025) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-020524-121438 · Cited by 32
Tang, S., Chen, X., Tong, X., & Zhu, L. (2025) · International Journal of Medical Sciences · doi:10.7150/ijms.112724 · Cited by 31
“Vargason et al. [221] suggest that cell therapies could significantly the bio-acceptability challenges encountered by DDSs.”
BSA-magnetite nanotorpedo for safe and efficient delivery of chemotherapy drugs
Zhao, X., Xu, S., Jiang, Y. Q., Wang, C., Rehman, S. U., Ji, S., Wang, J., Tao, T., Xu, H., Chen, R., et al. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.140440 · Cited by 28
Recent Advances in Bioelectronics for Localized Drug Delivery
Jiang, X., Wu, H., Xiao, A., Huang, Y., Yu, X., & Chang, L. (2023) · Small Methods · doi:10.1002/smtd.202301068 · Cited by 28
Achieving Precision Healthcare through Nanomedicine and Enhanced Model Systems
Svensson, E., von Mentzer, U., & Stubelius, A. (2023) · ACS Materials Au · doi:10.1021/acsmaterialsau.3c00073 · Cited by 30
Metadata
- Authors
- Vargason, A. M., Anselmo, A. C., & Mitragotri, S.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Harvard University (US)
- Corresponding author
- Mitragotri, Samir
- Venue
- Nature Biomedical Engineering
- Published
- 2021-04-01
- Volume
- 5
- Issue
- 9
- Pages
- 951-967
- ISSN
- 2157-846X (ISSN-L)
- OpenAlex
- W3143156272
- Cited by
- 1,361
- References
- 275
- Citations by year
- 2026: 170 · 2025: 314 · 2024: 366 · 2023: 293 · 2022: 170 · 2021: 48
- FWCI
- 19.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Nature Biomedical Engineering (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Science Foundation (DGE-1650116)
- U.S. Department of Health & Human Services | National Institutes of Health (R35GM137898, 1R01HL143806-01)
- United States Department of Defense | Defense Threat Reduction Agency (HDTRA1-15-1-0045)
- U.S. Department of Defense (W81XWH-19-2-0011)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- drug delivery technology, small molecules, macromolecules, nucleic acids, proteins, immunoglobulins, medication adherence
- MeSH terms
- Pharmaceutical Preparations, Humans, Nucleic Acids, Peptides, Proteins, Drug Delivery Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review